Clinical Trial Update: Preventing Osteoporosis Using Denosumab [Phase 4]

View source ↗

Summary

Phase 4 clinical trial results for denosumab in preventing osteoporosis have been posted after study completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Osteoporotic Fractures
• Postmenopausal Osteoporosis

Drugs mentioned

• Denosumab (Prolia) (denosumab)

Snippet

Sponsor: Susan L. Greenspan | Conditions: Osteoporosis, Postmenopausal, Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2024-09-19